The April 3 issue of The Medical Letter includes an article on the first treatment ever approved by the FDA for use in patients with dry age-related macular degeneration (AMD). More specifically, pegcetacoplan (Syfovre) was approved for treatment of geographic atrophy, which is a late stage of dry AMD. AMD is common; according to the […]
Single-Dose Treatment of Covid-19 with Pegylated Interferon Lambda
February 14, 2023 by Leave a Comment
The February 9th issue of The New England Journal of Medicine includes an article on a randomized controlled trial of a new antiviral treatment for Covid-19.1 Interferon lambda (IL-28 and -29) is an antiviral protein that has a protective effect at epithelial surfaces.2 It has been studied for antiviral activity against SARS-CoV-2 and in two […]
Underuse of Paxlovid
January 24, 2023 by 3 Comments
The combination of the oral antiviral nirmatrelvir and the protease inhibitor ritonavir (Paxlovid – Pfizer) has been available in the US since late December, 2021. In the clinical trial that led to the Emergency Use Authorization for Paxlovid, the drug decreased hospitalization or death, compared to placebo, by 88%.1 US COVID-19 deaths in 2022 averaged […]
TV Drug Ads
December 20, 2022 by 7 Comments
One of the many unsolicited messages that I receive daily on my computer screen informed me recently that Rinvoq has retaken the crown for top drug ad spender ($55.8 million in November) from Dupixent. I recall seeing unwanted TV ads for both drugs, but I had no idea that I was being visited by TV […]
Respiratory Syncytial Virus Infection
November 3, 2022 by Leave a Comment
Health authorities are warning of a looming triad this winter: COVID-19, influenza, and respiratory syncytial virus infections. Their emphasis has been on encouraging vaccination against COVID-19 and influenza. No vaccine is available for prevention of RSV infection, but one monoclonal antibody is available, and several vaccines and more monoclonal antibodies are in development.1 Most children […]
USPSTF Indications for Statins for Primary Prevention of CV Disease
September 19, 2022 by 1 Comment
Statins are recommended for virtually all patients who have atherosclerotic cardiovascular disease (ASCVD), but the indications for prevention of ASCVD are less clear. The US Preventive Services Task Force (USPSTF) recommendation statement on statin use for primary prevention of cardiovascular disease was recently published in the Journal of the American Medical Association.1 The USPSTF lists […]
Vitamin D Supplements
August 3, 2022 by 1 Comment
The July 28th issue of The New England Journal of Medicine included results from a large, randomized, placebo-controlled trial of vitamin D supplementation to lower the risk of fractures in middle-aged and older adults who were not selected based on gender, vitamin D deficiency, low bone mass, or osteoporosis. Supplementation with vitamin D3 2000IU/day did […]
More@MedLetter 